Updated on 13 October 2026
Legal, regulatory & ELSI partner (health law and emerging technologies)
Tenure-Track Assistant Professor at Sant'Anna School of Advanced Studies
Pisa, Italy
About
I am a Tenure-Track Assistant Professor of Comparative Private Law at Sant’Anna School of Advanced Studies (Pisa, Italy), affiliated with the DIRPOLIS Institute, the LIDER Lab and the Interdisciplinary Health Science Center.
I am a legal scholar and conduct academic legal research. I am looking for consortia that need a research partner mainly for the legal, ethical and societal dimensions of the following topics:
-
HORIZON-HLTH-2027-03-TOOL-08 – Towards the next generation of frontier Artificial Intelligence models for healthcare
-
HORIZON-HLTH-2027-01-CARE-02 – Personalised approaches to reduce risks from Adverse Drug Reactions due to multiple medications
-
HORIZON-HLTH-2027-02-TOOL-01-two-stage – Predictive biomarkers of disease progression and treatment response using AI methodologies for chronic non-communicable diseases
Research I can contribute
-
Comparative and EU legal analysis of the regulation of medicines and medical devices (including the pharmaceutical and MDR/IVDR reforms), off-label use and pharmacovigilance
-
Research on civil and product liability for medicines and AI-driven medical devices (revised Product Liability Directive)
-
Legal analysis of how the AI Act and the MDR apply to AI-based decision-support tools and continuously learning AI medical devices
-
Research on health data governance: GDPR, European Health Data Space, biobanks, consent models and secondary use of data
-
ELSI work packages, stakeholder engagement, policy recommendations and training
-
Dissemination, summer schools and capacity building
This research can inform a project's regulatory strategy, but I do not provide compliance assessments or certification support.
Relevant experience
-
PI of the Jean Monnet Module PERSONA, “Law for Personalising Medicine in the EU” (2025–present)
-
Former Marie Skłodowska-Curie Individual Fellow (FullCompensation, Maastricht University) and former postdoctoral legal researcher in H2020, Nordforsk and regional projects on health data and biobanking (ENLIGHTENme, CG, CHRIS-2D)
-
Author of The Law of Off-label Uses of Medicines (Routledge, 2022) and of numerous peer-reviewed articles on medicines regulation, AI-powered medical devices, data sharing and the EHDS
For further details, see my CV in the uploeaded files.
What I am looking for
I am interested in joining as a partner or work package leader for the legal, ethical, and policy-oriented research tasks, from proposal writing through implementation
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
- Consortium/Coordinator seeks Partners
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Abdulkadir Kayıklı
Founder at Finakis
Istanbul, Türkiye
Project cooperation
Non-invasive gynaecological biomarkers and diagnostics (GyLDa platform), focus on endometriosis
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Cristina Vilarmau
Head of Business Development & Innovation at Mimark Diagnostics S.L
Barcelona, Spain
Project cooperation
Nurse researcher and Professor in Nursing Science
Dhurata Ivziku
nurse researcher at Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy